RESPIROLOGY

Case sharing: Tezepelumab targets upstream inflammation to bridge the divide in both severe T2-high and -low asthma

19 Nov 2025

Beyond breathlessness: The evolving landscape of ILD management

20 May 2025

HFNC oxygen supplementation and SF ratio prognostication in the COVID-19 pandemic

14 Mar 2024

Fixed-duration immunotherapy demonstrates comparable survival benefits in advanced NSCLC

11 Jul 2023

Dupilumab demonstrates long-term safety and efficacy among children with type 2 asthma: The EXCURSION study

15 May 2023

Targeting TSLP for severe asthma - Tezepelumab updates from the 2023 American Academy of Allergy Asthma & Immunology Annual Meeting

06 Apr 2023

Remission is within reach - Target the underlying drivers of inflammation with benralizumab

19 Sep 2022

The potential new first-line mNSCLC treatment regardless of PD-L1: Durvalumab + tremelimumab + chemotherapy improved survival

03 May 2022

Using adjuvant osimertinib to treat resected EGFR mutationpositive NSCLC in early stages: A local case sharing

27 Feb 2022
Expert Insight View All

Beyond breathlessness: The evolving landscape of ILD management

Interstitial lung disease (ILD) presents as a diverse group of lung disorders, where inflammation and fibrosis drive a highly variable disease course.1,2 While some patients experience mild symptoms, others progress to debilitating respiratory failure, highlighting the unpredictable nature of ILD.1,
20 May 2025
thumb

Dr. Syazatul Syakirin Sirol Aflah

Consultant Respiratory Physician,
Institut Perubatan Respiratori (IPR),
Kuala Lumpur, Malaysia

HFNC oxygen supplementation and SF ratio prognostication in the COVID-19 pandemic

In an interview, Dr. Tong, Chak-Kwan and Dr. Chan, Yu-Hong John shared their recently published study on the learnings from HFNC use in the general ward setting, describing its benefits in terms of 28-day mortality.
14 Mar 2024
thumb

Dr. Chan, Yu-Hong John

Specialist in Respiratory Medicine
thumb

Dr. Tong, Chak-Kwan

Specialit in Critical Care Medicine, 
Adult Intensive Care Unity, 
Tuen Mun Hospital
Conference update View All
thumb

ERS 2023

September 9 - 13, 2023 | Milan, Italy

Meeting Highlight View All

Adopting durvalumab consolidation therapy: A breakthrough for non-small cell lung cancer treatment

ONCOLOGY RESPIROLOGY
10 Dec 2021
thumb

Dr. Lee, Ho-Fun Victor

Clinical Associate Professor,
Department of Clinical Oncology,
The University of Hong Kong
thumb

Dr. Chan, Siu-Hong Oscar

Specialist in Clinical Oncology,
Hong Kong Integrated Oncology Centre
thumb

Dr. Nyaw, Shi-Feng Jonathan

Specialist in Clinical Oncology,
Department of Clinical Oncology,
Tuen Mun Hospital
Case review View All

Case sharing: Tezepelumab targets upstream inflammation to bridge the divide in both severe T2-high and -low asthma

Asthma is a complex, chronic respiratory disease characterized by heterogeneous airway inflammation and variable clinical presentation.1 Within its spectrum, severe asthma represents a high-burden subgroup that contributes disproportionately to morbidity, healthcare utilization, and mortality.1,2 De
19 Nov 2025
thumb

Professor Li, Hei Philip

Specialist in Immunology & Allergy,
Division Chief of Rheumatology & Clinical Immunology, Clinical Assistant Professor,
Department of Medicine,
The University of Hong Kong
thumb

Dr. Leung, Kei-Ching Gabriel

Enrichment Year MBBS student,
Li Ka Shing Faculty of Medicine,
The University of Hong Kong
Research Spotlight View All

Awake prone positioning in the pandemic era: A potential alternative to prevent IMV in patients with respiratory failure

In brief The 18-day single-center experience of awake prone position (APP) in patients admitted to the intensive care unit (ICU) of Pamela Youde Nethersole Eastern Hospital in Hong Kong (PYNEH) with severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection demonstrated the effectiveness
28 Jan 2022
thumb

Dr. Lam, Sin-Man Grace

Department of Intensive Care,
Pamela Youde Nethersole Eastern Hospital
thumb

Dr. Man, Man-Yee

Department of Intensive Care, Pamela Youde Nethersole Eastern Hospital

Prone positioning in non-intubated patients with coronavirus – A single centre experience

MY Man, SM Lam, HP Shum, KC Li, S Lau, VHL Ip , WW Yan
News & perspective View All

Short-course inhaled amikacin therapy reduces the risk of VAP in patients who received recent invasive mechanical ventilation

Ventilator-associated pneumonia (VAP) is a common nosocomial infection associated with significant morbidity, especially for patients in intensive care units (ICU).1 Previous clinical trials had evaluated the use of inhaled preventive antibiotics such as colistin, ceftazidime, and gentamicin in pati
03 Jan 2024

Reducing unnecessary antibiotics use in children with acute sinusitis through bacterial testing

A recent randomized clinical trial suggests that undergoing testing for specific nasopharyngeal bacteria in children with acute sinusitis could identify those who will benefit most from antibiotic treatment.1 Consequently, this could in turn substantially reduce antibiotic use among pediatric patien
11 Sep 2023
Infographics View All
RESPIROLOGY

Brain Gliosis: A Potential Origin of Persistent Post-COVID-19 Depressive and Cognitive Symptoms

17 Nov 2023
Features

Case sharing: Tezepelumab targets upstream inflammation to bridge the divide in both severe T2-high and -low asthma

Asthma is a complex, chronic respiratory disease characterized by heterogeneous airway inflammation and variable clinical presentation.1 Within its spectrum, severe asthma represents a high-burden subgroup that contributes disproportionately to morbidity, healthcare utilization, and mortality.1,2 De
19 Nov 2025
thumb

Professor Li, Hei Philip

Specialist in Immunology & Allergy,
Division Chief of Rheumatology & Clinical Immunology, Clinical Assistant Professor,
Department of Medicine,
The University of Hong Kong
thumb

Dr. Leung, Kei-Ching Gabriel

Enrichment Year MBBS student,
Li Ka Shing Faculty of Medicine,
The University of Hong Kong